QIAGEN N.V. QGEN announces the launch of QIAstat-Dx Rise — a version of the QIAstat-Dx automated syndromic testing system that offers enhanced throughput with the easiest workflow available to ...

Qiagen launches US FDA approved higher-throughput QIAstat-Dx Rise, a version of the QIAstat-Dx automated syndromic testing system: Germantown, Maryland Wednesday, September 3, 202 ...

Seegene Inc., a global leader in molecular diagnostics, announced today the launch of the 2025–2026 Nature Awards MDx Impact Grants ...

South Korea has officially designated Nipah virus infection as a first-tier infectious disease, a classification for the most ...

U.S. market entry set to begin for QIAstat-Dx Rise – a version of QIAstat-Dx for syndromic testing that combines unparalleled throughput with the easiest workflowQIAstat-Dx Rise launch can process up ...

Last week, I was about to go on a date, and because I'm severely immunocompromised, we agreed he would take a COVID test using one of my rapid home PCR tests. It was a courtesy—he felt perfectly ...

The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026- Selected ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 /EINPresswire.com/ -- Genetic Analysis Market Growth Forecast: What To Expect By 2025? The market size for genetic analysis has seen a swift ...

With the new certification, the full portfolio of QiaStat-Dx qPCR-based multiplex panels and instruments is now CE-IVDR certified.

Qiagen N.V. ( NYSE: QGEN) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:05 PM EDT ...